Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

468 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-31

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-interventional study to gain further information about the therapy progression in routine treatment of adults with attention-deficit/hyperactivity disorder (ADHD). Main focus will be on the improvement of the clinical global impression (CGI) in comparison to the outcome of randomized, controlled studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach

NCT01678209

Attention Deficit Hyperactivity Disorder ADHD

COMPLETED PHASE4

Psychological Treatment for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT01659164

ADHD

COMPLETED NA

Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders

NCT01618110

Attention Deficit/Hyperactivity Disorder

UNKNOWN NA

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

NCT04943796

Attention Deficit Hyperactivity Disorder (ADHD)

COMPLETED

Brain Activity in Adults With ADHD During Neuropsychological Tasks

NCT02578342

Attention Deficit Hyperactivity Disorder (ADHD)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adult Attention-deficit/Hyperactivity Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients with newly diagnosed ADHD

Exclusion Criteria

* Known sensitivity to methylphenidate or any of the excipients
* Glaucoma
* Phaeochromocytoma
* During treatment with non-selective, irreversible monoamine oxidase (MAO) inhibitors, or within a minimum of 14 days of discontinuing those drugs, due to risk of hypertensive crisis
* Hyperthyroidism or Thyrotoxicosis
* Diagnosis or history of severe depression, anorexia nervosa/anorexic disorders, suicidal tendencies, psychotic symptoms, severe mood disorders, mania, schizophrenia, psychopathic/borderline personality disorder.
* Diagnosis or history of severe and episodic (Type I) Bipolar (affective) Disorder (that is not well-controlled)
* pre-existing cardiovascular disorders including severe hypertension, heart failure, arterial occlusive disease, angina, haemodynamically significant congenital heart disease, cardiomyopathies, myocardial infarction, potentially life-threatening arrhythmias and channelopathies (disorders caused by the dysfunction of ion channels)
* pre-existing cerebrovascular disorders cerebral aneurysm, vascular abnormalities including vasculitis or stroke
* a history of pronounced anacidity of the stomach with a pH value above 5.5, in therapy with H2-receptor blockers or in antacid therapy,

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No